BHP (ASX:BHP) delivers record dividend of US$1.01

16Feb

BHP (ASX:BHP) delivers record dividend of US$1.01

 

BHP (ASX:BHP) is to offer shareholders a higher-than-expected $US1.01 per share dividend after reporting underlying profit had increased 16 per cent to $US6.3 billion over the half year.

Net operating cash flow of US$9.4 billion and free cash flow of US$5.2 billion reflects higher iron ore and copper prices and strong operational performance.

BHP Chief Executive Officer, Mike Henry says: “Our continued delivery of reliable operational performance during the half supported record production at Western Australia Iron Ore and record concentrator throughput at Escondida”.

Shares in BHP (ASX:BHP) are trading 1.03 per cent higher at $46.22.
 
Copyright 2021 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

19Aug

Stocks of the Hour: Bendigo Bank, Beach Energy & Lendlease

16 Aug 2021 - A snapshot of the stocks on the move, featuring Bendigo and Adelaide Bank (ASX:BEN), Beach Energy (ASX:BPT) & Lendlease (ASX:LLC).

Read More
01Sep

QBE Insurance Group’s (ASX:QBE) CEO to leave the company

01 Sept 2020 - QBE Insurance Group (ASX:QBE) today announced that their Group Chief Executive Officer Pat Regan will be departing the organisation after almost three years in the role.

Read More
29Mar

NRW Holdings (ASX:NWH) receive two contract updates for Golding

29 Mar 2021 - NRW Holdings (ASX:NWH) wholly owned subsidiary, Golding Contractors Pty Ltd has been awarded a 3 year term contract to complete general subdivision and associated infrastructure works at Lendlease’s Yarrabilba residential development in Queensland.

Read More
27Feb

Flight Centre Travel Group (ASX:FLT) report 1H NPAT down 74%

27 Feb 2020 - Flight Centre Travel Group (ASX:FLT) report a net profit after tax (NPAT) of $22.1 million, that’s 74 per cent less than the prior corresponding period.

Read More
15Dec

Mesoblast (ASX:MSB) report improved outcome in heart failure patients

15 Dec 2020 - Cellular medicine company Mesoblast (ASX:MSB) announced top-line results from the landmark DREAM-HF Phase 3 trial of its allogeneic cell therapy rexlemestrocel-L (REVASCOR®) in 537 patients with advanced chronic heart failure.

Read More
18May

Stocks of the Hour: Eagers Automotive, Boral & EMVision Medical

18 May 2022 - A snapshot of the stocks on the move featuring Eagers Automotive (ASX:APE), Boral (ASX:BLD) & EMVision Medical Devices (ASX:EMV).

Read More
21Dec

Silver Lake Resources (ASX:SLR) to divest Andy Well and Gnaweeda projects

21 Dec 2020 - Silver Lake Resources (ASX:SLR) has agreed to divest the Andy Well and Gnaweeda projects in Western Australia to Latitude Consolidated (ASX:LCD) for cash consideration of $8 million.

Read More
02Dec

Zip Co (ASX:Z1P) to raise $60m through placements

02 Dec 2019 - Zip Co (ASX:Z1P) has received firm commitments to raise $60 million before costs via a placement.

Read More
30Nov

Unexpected resignation of Oil Search’s (ASX:OSH) CFO hire

27 Nov 2020 - Oil Search’s (ASX:OSH) Chief Financial Officer Designate, Ayten Saridas has resigned from her position.

Read More
07Jan

Stocks of the Hour: API, Magellan, Pinnacle Investment

07 Jan 2022 - A snapshot of the stocks on the move featuring Priceline owner (ASX:API), Magellan Financial Group (ASX:MFG), and Pinnacle Investment (ASX:PNI).

Read More